[144] Taysha Gene Therapies, Inc. SEC Filing

Rhea-AI Filing Summary

Taysha Gene Therapies (TSHA) filing a Form 144 notifies the planned sale of 10,770 shares of common stock through Maxim Group on Nasdaq with an aggregate market value of $30,479.10. The shares were acquired and vested as RSU awards on 09/22/2025 and settled in stock as consideration for the reporting person’s service. The filing shows 272,794,885 shares outstanding and reports no other sales in the past three months. The filer certifies no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale disclosure of vested RSUs; transaction size is immaterial to total shares outstanding.

The Form 144 documents a planned sale of 10,770 shares via a broker on Nasdaq, stemming from RSUs that vested and were settled in stock on the same date. With 272.8 million shares outstanding, the position represents roughly 0.0039% of the outstanding stock, indicating limited direct market impact. The filing includes the required certification regarding material nonpublic information.

Corporate Governance Expert

TL;DR: Standard disclosure consistent with Rule 144 procedures following RSU vesting and settlement.

The notice provides the broker name, exact share count, acquisition and planned sale date, and nature of acquisition (RSU award). It confirms no sales in the prior three months and includes the statutory signature caution, fulfilling disclosure obligations under the rule. No governance or compliance issues are evident from the content provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Maxim Group LLC 300 Park Avenue, 16th Floor New York NY 10022	10770	30479.1	272794885	09/22/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/22/2025	RSU Award	Issuer			10770	09/22/2025	Vested grant settled instock; consideration was Reporting Person's continued service as an employee ofthe Issuer.

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TSHA Form 144 report?

The filing reports a proposed sale of 10,770 common shares acquired via RSU vesting and settled in stock on 09/22/2025.

Who is the broker handling the proposed TSHA sale?

The broker named in the filing is Maxim Group LLC, with the sale to occur on Nasdaq.

What is the aggregate market value of the shares to be sold for TSHA?

The aggregate market value reported is $30,479.10 for the 10,770 shares.

How do these shares compare to TSHA's outstanding shares?

The filing lists 272,794,885 shares outstanding; the 10,770-share sale is approximately 0.0039% of that total.

Were there any other sales by the reporting person in the past three months?

The filing states Nothing to Report for securities sold during the past three months.